Send us message to learn more about InnoHK
CONTACT US
Eye Health

Centre for Eye and Vision Research

Centre for Eye and Vision Research

Building the Foundation for a Global Population with 20/20 Vision

PolyU and Waterloo are both well known for pursuing world-class, innovative research, and both have excellent reputations in eye and vision health research and development. I am delighted that our institutions are launching CEVR in Hong Kong as a significant step in enhancing both our research capacities and collaboration in addressing eye and vision health challenges. I look forward to seeing high-impact translational research and innovative applications from CEVR that can benefit people in the region and around the world.
Professor Benjamin Thompson

CEO and Scientific Director, CEVR,
Professor, School of Optometry and Vision Science, University of Waterloo

Building the Foundation for a Global Population with 20/20 Vision

In a world built on the ability to see, vision, the most dominant of our senses, is vital at every turn of our lives. Yet, more than one-third of the world’ s population, or 2.2 billion people, suffer some form of vision impairment, with the ailment being particularly acute in Asia. At least half of these sufferers could have prevented their vision loss, if they had access to better medical care[1].

CEVR will conduct cutting edge clinical research into new technologies for preventing vision loss.

CEVR will conduct cutting edge clinical research into new technologies for preventing vision loss.

Team members including Prof. Robert Lemieux, Dean of Science and Professor of Chemistry at Waterloo (front right), Prof. David Shum, Dean of the Faculty of Health and Social Sciences at PolyU (front left), and Nobel Laureate Prof. Donna Strickland, Professor of Physics and Astronomy at Waterloo (front, second left).

Team members including Prof. Robert Lemieux, Dean of Science and Professor of Chemistry at Waterloo (front right), Prof. David Shum, Dean of the Faculty of Health and Social Sciences at PolyU (front left), and Nobel Laureate Prof. Donna Strickland, Professor of Physics and Astronomy at Waterloo (front, second left).

New technologies for detecting and diagnosing eye and brain diseases are being developed within CEVR.

New technologies for detecting and diagnosing eye and brain diseases are being developed within CEVR.

CEVR Clinical Laboratory

CEVR Clinical Laboratory

CEVR Bioscience Laboratory

CEVR Bioscience Laboratory

The Centre for Eye and Vision Research (CEVR) is at the forefront of this population’s health and aging imperative, promoting eye health with clinical, basic and applied research, developing ground-breaking technologies designed to prevent vision loss and preserve sight among the aging population. Ultimately, the Centre is committed to becoming a global hub for eye and vision research to improve eye health in Hong Kong, mainland China and the rest of the world.

A catalyst for advanced collaborations among eye health researchers in Asia, Europe and North America, CEVR offers an environment for cross-disciplinary collaborations and discoveries that can lead to disruptive new technologies. The Centre will run five research programmes, including Myopia and Eye Growth, Ocular Drug Discovery and Delivery, Vision Enhancement, Tear Film and Ocular Surface, and Advanced Optometric Technology.

By combining the vibrant entrepreneurial culture and proven track record in translational research and knowledge transfer of The Hong Kong Polytechnic University (PolyU) and University of Waterloo (Waterloo), and harnessing the research expertise and entrepreneurial ecosystem in Hong Kong, CEVR aims to attract spin-offs and large multinationals from the biomedical research and innovation supercluster in the Greater Bay Area. The Centre will be a global leader in biomedical science and technology — a magnet in attracting and training elite researchers, visitors, industrial partners and entrepreneurs.

[1] World Health Organization: World Report on Vision (2019)

Project team members

  • Prof Benjamin Thompson
    Prof Benjamin Thompson

    Chief Executive Officer

  • Prof Chi-ho To
    Prof Chi-ho To

    Chief Operating Officer

In this project

You may also like

Center for Neuromusculoskeletal Restorative Medicine (CNRM)
Center for Neuromusculoskeletal Restorative Medicine (CNRM)
The initiatives for setting up the CNRM, with its thematic & multi- disciplinary nature and collaboration between the two world-class research institutions, present a very unique strength to accelerate R&D breakthrough in neuromusculoskeletal disease. It will certainly strengthen the stature and commitment of Hong Kong as an advanced R&D hub in the region.

OUR TEAM

Professor Patrick Yung, Professor Woody Chan
Microbiota I-Center (MagIC)
Microbiota I-Center (MagIC)
The Microbiota I-Center (MagIC) is determined to harness and empower microbiome into cutting-edge innovations that will transform lives of patients and their families. We are committed to developing novel classes of microbiome diagnostics and therapeutics that will accelerate Hong Kong into a world-class microbiome biotechnology hub.

OUR TEAM

Professor Siew C. Ng, Professor Francis Chan
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
We will recruit top-notch talent locally, from Mainland China, as well as from overseas thanks to the international environment and unique legal system in Hong Kong. To connect with the renowned biomedical institutions and hospitals in the region, we aim to conduct world-class, cutting-edge collaborative biomedical research.

OUR TEAM

Prof. Duanqing Pei , Prof. Guangjin Pan
Virology
Centre for Virology, Vaccinology and Therapeutics
Centre for Virology, Vaccinology and Therapeutics
Infectious diseases can have devastating health, social and economic consequences locally and globally. By taking this opportunity to set up a research laboratory to conduct collaborative research with world-renowned institutions at InnoHK, CVVT serves as the hub for the incubation of basic research, and the translation of impactful discoveries into applications for the control and prevention of infectious diseases.

OUR TEAM

CVVT ,
Centre for Virology, Vaccinology and Therapeutics

Find your interest